Orthofix earns FDA clearance for transverse bone transplant system

Advertisement

Orthofix’s TrueLok Elevate transverse bone transplant system earned FDA 510(k) clearance and CE Mark from the European Union.

TrueLok Elevate is designed for limb preservation and addresses bony or soft tissue deformities, according to a March 19 news release. The system lets surgeons use an efficient and reproducible method to create bone segments in the tidbits that can be gradually distracted.

It’s available in a limited market release.

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Orthopedic

Advertisement